JP2022505107A5 - - Google Patents
Info
- Publication number
- JP2022505107A5 JP2022505107A5 JP2021521016A JP2021521016A JP2022505107A5 JP 2022505107 A5 JP2022505107 A5 JP 2022505107A5 JP 2021521016 A JP2021521016 A JP 2021521016A JP 2021521016 A JP2021521016 A JP 2021521016A JP 2022505107 A5 JP2022505107 A5 JP 2022505107A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- cell
- antigen
- chimeric molecule
- molecule according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18201560 | 2018-10-19 | ||
| EP18201560.2 | 2018-10-19 | ||
| PCT/EP2019/078449 WO2020079264A1 (en) | 2018-10-19 | 2019-10-18 | Chimeric molecules |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022505107A JP2022505107A (ja) | 2022-01-14 |
| JP2022505107A5 true JP2022505107A5 (https=) | 2022-10-24 |
Family
ID=63965155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021521016A Pending JP2022505107A (ja) | 2018-10-19 | 2019-10-18 | キメラ分子 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20210324037A1 (https=) |
| EP (1) | EP3867268A1 (https=) |
| JP (1) | JP2022505107A (https=) |
| KR (1) | KR20210081345A (https=) |
| CN (1) | CN112930355A (https=) |
| AU (1) | AU2019362400A1 (https=) |
| BR (1) | BR112021007418A2 (https=) |
| CA (1) | CA3115007A1 (https=) |
| EA (1) | EA202191083A1 (https=) |
| IL (1) | IL282230A (https=) |
| MX (1) | MX2021004355A (https=) |
| WO (1) | WO2020079264A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109321569B (zh) * | 2018-10-29 | 2022-04-12 | 迈杰转化医学研究(苏州)有限公司 | 一种引物探针组合物及其应用 |
| EP4638712A2 (en) * | 2022-12-22 | 2025-10-29 | Bluesphere Bio, Inc. | Methods for identifying t cell receptors (tcrs) that bind antigens |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU765085B2 (en) * | 1998-05-11 | 2003-09-11 | Miltenyi Biotec Gmbh | Method of direct selection of antigen-specific T cells |
| ES3009756T3 (en) * | 2013-08-05 | 2025-03-31 | Immatics Biotechnologies Gmbh | Novel immunotherapy against several tumors, such as lung cancer including nsclc |
| US20160177284A1 (en) * | 2014-01-27 | 2016-06-23 | Molecular Templates, Inc. | Cell-targeted molecules comprising amino-terminus proximal or amino-terminal shiga toxin a subunit effector regions |
| CN107223051B (zh) * | 2014-12-17 | 2021-09-03 | 斯坦福国际研究院 | 抗原递送系统 |
| EP3851450B1 (en) * | 2014-12-19 | 2024-11-27 | ETH Zürich | Chimeric antigen receptors and methods of use |
| CN105504018B (zh) * | 2016-01-13 | 2019-01-04 | 郑州大学 | Lag-3亲和肽n13、制备方法及其应用 |
| CN107286246B (zh) * | 2016-12-28 | 2019-12-17 | 时力生物科技（北京）有限公司 | 治疗脑胶质瘤的嵌合抗原受体修饰的树突状细胞及其制备方法 |
-
2019
- 2019-10-18 CA CA3115007A patent/CA3115007A1/en active Pending
- 2019-10-18 CN CN201980068875.6A patent/CN112930355A/zh active Pending
- 2019-10-18 BR BR112021007418-0A patent/BR112021007418A2/pt not_active Application Discontinuation
- 2019-10-18 KR KR1020217011241A patent/KR20210081345A/ko not_active Withdrawn
- 2019-10-18 MX MX2021004355A patent/MX2021004355A/es unknown
- 2019-10-18 JP JP2021521016A patent/JP2022505107A/ja active Pending
- 2019-10-18 WO PCT/EP2019/078449 patent/WO2020079264A1/en not_active Ceased
- 2019-10-18 AU AU2019362400A patent/AU2019362400A1/en not_active Abandoned
- 2019-10-18 EA EA202191083A patent/EA202191083A1/ru unknown
- 2019-10-18 EP EP19786822.7A patent/EP3867268A1/en not_active Withdrawn
- 2019-10-18 US US17/285,338 patent/US20210324037A1/en not_active Abandoned
-
2021
- 2021-04-11 IL IL282230A patent/IL282230A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250188145A1 (en) | Tcr and peptides | |
| US11001621B1 (en) | Trifunctional T cell-antigen coupler and methods and uses thereof | |
| JP6612963B2 (ja) | 腫瘍抗原を直接認識するために組換えｔ細胞レセプターを使用するための組成物及び方法 | |
| JP2021137024A5 (https=) | ||
| Tsuji et al. | Generation of tumor-specific, HLA class I–restricted human Th1 and Tc1 cells by cell engineering with tumor peptide–specific T-cell receptor genes | |
| JP2021521776A5 (https=) | ||
| JP7687952B2 (ja) | 血液腫瘍を治療するための遺伝子操作しているγδ－Ｔ細胞及び遺伝子操作していないγδ－Ｔ細胞に関する組成物及び方法 | |
| CN107995926B (zh) | 嵌合抗原受体和使用方法 | |
| JP2018513683A5 (https=) | ||
| US20220119477A1 (en) | Tcr and peptides | |
| WO2017222619A2 (en) | Sequence arrangements and sequences for neoepitope presentation | |
| JP7227630B2 (ja) | Ｙ１８２ｔ突然変異を有するｔ細胞－抗原カプラおよびその方法ならびに使用 | |
| JP2022505107A5 (https=) | ||
| JP7518915B2 (ja) | Ｃｄ３融合タンパク質およびその使用 | |
| Ikeda et al. | Generation of human tumor-specific, HLA class I-restricted Th1 and Tc1 |